{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-079689","form_type":"8-K","ticker":"CLSDQ","cik":"0001539029","company_name":"Clearside Biomedical, Inc.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.695562+00:00","generated_at":"2026-05-20T04:20:52.303587+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Clearside Biomedical shareholders approve doubling authorized common stock to 400M shares","bullets":["Shareholders approved amendment to increase authorized common shares from 200M to 400M; 38.8M for, 10.3M against, 0.6M abstain.","All three director nominees (Lasezkay, Shaffer, Gibney) were elected with >25M votes for.","Advisory vote on executive compensation approved: 18.9M for, 3.4M against, 6.8M abstain.","Ratification of Ernst & Young as auditor for FY2025 approved: 48.5M for, 1.2M against."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-079689","json":"https://secwatch.observer/filing/0000950170-25-079689.json","markdown":"https://secwatch.observer/filing/0000950170-25-079689.md","text":"https://secwatch.observer/filing/0000950170-25-079689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1539029/000095017025079689/0000950170-25-079689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1539029/000095017025079689/clsd-20250530.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:20:52.303587+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d8d8d05ec80a540f2ec7a4679563719a6f79a228","claim":"Clearside Biomedical, Inc.: Increased authorized shares of common stock from 200,000,000 to 400,000,000 (effective 2025-05-30).","evidence_excerpt":"the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “ Amendment ”) to increase the authorized number of shares of common stock from 200,000,000 to 400,000,000","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1539029/000095017025079689/0000950170-25-079689-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-05-30"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}